Liu Yueting, Jin Xiaolin, Fu Kailei, Li Jinwei, Xue Weishuang, Tian Li, Teng Weiyu
Department of Neurology, the First Affiliated Hospital, China Medical University, Shenyang, China.
Department of Geriatrics, Shengjing Hospital, China Medical University, Shenyang, China.
Nutr Metab Cardiovasc Dis. 2023 Apr;33(4):698-714. doi: 10.1016/j.numecd.2023.01.003. Epub 2023 Jan 11.
An increasing number of studies on non-traditional lipid profiles have been investigated in recent years. However, the associations between non-traditional lipid profiles and the risk of stroke remained inconsistent. Therefore, this meta-analysis aimed to evaluate the associations between non-traditional lipid profiles and the risk of stroke and clarify the dose-response relations.
We performed a systematic literature search in PubMed, Embase, and Web of Science databases until 1 November 2022 for relevant studies. Relative risks and 95% confidence intervals were pooled by random-effects or fixed-effects models. A total of 26 full-text studies with 676678 participants and 18057 stroke cases were eligible for the final study. We found a positive association between the risk of stroke and total cholesterol to high-density lipoprotein cholesterol (TC/HDL-C) ratio (RR = 1.19,95%CI = 1.00-1.40, I = 74.6%), triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio (RR = 1.24,95%CI = 1.10-1.41, I = 62.8%) or low-density lipoprotein cholesterol to high-density lipoprotein cholesterol (LDL-C/HDL-C) ratio (RR = 1.24, 95%CI = 1.11-1.39, I = 49.4%). When focusing on the stroke subtype, a more significant association was observed between the risk of ischemic stroke and four non-traditional lipid profiles. In dose-response analysis, we found a linear association between TC/HDL-C ratio and the risk of stroke (RR = 1.16,95%CI = 1.07-1.26).
Elevated non-traditional lipid profiles were associated with an increased risk of ischemic stroke. The linear association showed the risk of stroke increased by 16% when the pooled RR of TC/HDL-C ratio per 1-unit increased.
CRD42022321251.
近年来,关于非传统血脂谱的研究越来越多。然而,非传统血脂谱与中风风险之间的关联仍不一致。因此,本荟萃分析旨在评估非传统血脂谱与中风风险之间的关联,并阐明剂量反应关系。
我们在PubMed、Embase和Web of Science数据库中进行了系统的文献检索,直至2022年11月1日,以查找相关研究。采用随机效应或固定效应模型汇总相对风险和95%置信区间。共有26项全文研究符合最终研究标准,涉及676678名参与者和18057例中风病例。我们发现中风风险与总胆固醇与高密度脂蛋白胆固醇(TC/HDL-C)比值(RR = 1.19,95%CI = 1.00 - 1.40,I = 74.6%)、甘油三酯与高密度脂蛋白胆固醇(TG/HDL-C)比值(RR = 1.24,95%CI = 1.10 - 1.41,I = 62.8%)或低密度脂蛋白胆固醇与高密度脂蛋白胆固醇(LDL-C/HDL-C)比值(RR = 1.24,95%CI = 1.11 - 1.39,I = 49.4%)之间存在正相关。当关注中风亚型时,缺血性中风风险与四种非传统血脂谱之间的关联更为显著。在剂量反应分析中,我们发现TC/HDL-C比值与中风风险之间存在线性关联(RR = 1.16,95%CI = 1.07 - 1.26)。
非传统血脂谱升高与缺血性中风风险增加相关。线性关联表明,每单位TC/HDL-C比值的合并RR增加时,中风风险增加16%。
在PROSPERO中的注册号:CRD42022321251。